Tanneberger S
Arch Geschwulstforsch. 1979;49(8):740-6.
The clinical staging has much lesser importance in non-Hodgkin-lymphomas than in Hodgkin-lymphomas. Much more important for prognosis and treatment is there the histopathological subtype. For this reason there are many international activities directed to new ways of the histological classification of non-Hodgkin-lymphomas. Without any doubt Rappaport's proposal is the clinically most used non-Hodgkin-classification but more and more also the proposal of Lennert becomes accepted by clinicians. The immunological approach seemed to be the most promising way to qualify the Non-Hodgkin-lymphoma classification and finally to individualize the management of this type of neoplasia.
临床分期在非霍奇金淋巴瘤中比在霍奇金淋巴瘤中重要性要小得多。对于预后和治疗而言，组织病理学亚型更为重要。因此，有许多国际活动致力于非霍奇金淋巴瘤组织学分类的新方法。毫无疑问，拉帕波特的提议是临床上最常用的非霍奇金淋巴瘤分类方法，但越来越多的临床医生也接受伦纳特的提议。免疫学方法似乎是确定非霍奇金淋巴瘤分类并最终使这类肿瘤的治疗个体化的最有前景的方法。
